| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $0 | 1 | 50 |
Sells | $107,100 | 1 | 50 |
| GordonMD Global Investments LP | 10 percent owner | 1 | $0 | 0 | $0 | $0 |
| Dupont Jakob | director | 0 | $0 | 1 | $107,100 | $-107,100 |
Pyxis Oncology, Inc. operates as a preclinical biopharmaceutical company focused on developing novel therapeutic approaches to combat various forms of cancer. Its investigational immune-oncology pipeline includes PYX-106, a fully human immunoglobulin G1 (IgG1) antibody designed to target siglec-15, which is being explored for its potential efficacy against thyroid cancer, head and neck squamous cell carcinoma, non-small cell lung cancer (NSCLC), and other solid tumors. Additionally, PYX-102 is an immune-therapeutic currently under investigation …
Over the last 12 months, insiders at Pyxis Oncology, Inc. have bought $0 and sold $107,100 worth of Pyxis Oncology, Inc. stock.
On average, over the past 5 years, insiders at Pyxis Oncology, Inc. have bought $1.39M and sold $1.38M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 5,517,000 shares for transaction amount of $0 was made by GordonMD Global Investments LP (10 percent owner) on 2026‑10‑01.
| 2026-10-01 | GordonMD Global Investments LP | 10 percent owner | 5.52M – | $0 | $0 | -15.98% | ||
| 2026-06-30 | Sale | Dupont Jakob | director | 35,000 0.0562% | $3.06 | $107,100 | -4.82% | |
| 2025-04-21 | Sale | HUMPHREY RACHEL | director | 13,896 0.0244% | $1.03 | $14,362 | +37.74% | |
| 2025-04-17 | Sale | HUMPHREY RACHEL | director | 200 0.0003% | $0.97 | $194 | +50.52% | |
| 2025-04-14 | Sale | HUMPHREY RACHEL | director | 1,400 0.0023% | $0.97 | $1,362 | +57.38% | |
| 2024-11-26 | Connealy Pamela Ann | CFO & COO | 88,850 0.1619% | $1.96 | $174,364 | -25.42% | ||
| 2023-09-28 | Connealy Pamela Ann | CFO and COO | 8,000 0.0167% | $1.87 | $14,960 | +76.96% | ||
| 2023-09-27 | Connealy Pamela Ann | CFO and COO | 6,426 0.0147% | $1.85 | $11,868 | +95.92% | ||
| 2023-09-27 | Wadhane Jitendra | Chief Accounting Officer | 2,500 0.0058% | $1.87 | $4,675 | +95.92% | ||
| 2023-09-25 | Connealy Pamela Ann | CFO and COO | 12,000 0.0257% | $1.67 | $20,044 | +101.97% | ||
| 2023-09-25 | Wadhane Jitendra | Chief Accounting Officer | 5,000 0.0113% | $1.77 | $8,850 | +101.97% | ||
| 2023-09-22 | Connealy Pamela Ann | CFO and COO | 5,000 0.0124% | $1.74 | $8,695 | +123.75% | ||
| 2023-09-22 | Wadhane Jitendra | Chief Accounting Officer | 2,500 0.0062% | $1.74 | $4,349 | +123.75% | ||
| 2023-09-18 | Sale | Sullivan Lara | President and CEO | 8,541 0.02% | $2.10 | $17,936 | +73.77% | |
| 2023-09-14 | Sale | Sullivan Lara | President and CEO | 100 0.0002% | $2.25 | $225 | +60.55% | |
| 2023-09-13 | Sale | Sullivan Lara | President and CEO | 3,000 0.007% | $2.27 | $6,816 | +56.25% | |
| 2023-09-12 | Sale | Sullivan Lara | President and CEO | 4,917 0.0114% | $2.25 | $11,071 | +57.21% | |
| 2023-09-11 | Sale | Sullivan Lara | President and CEO | 20,000 0.045% | $2.27 | $45,414 | +51.30% | |
| 2023-03-17 | PFIZER INC | 10 percent owner | 1.81M 5.1245% | $2.76 | $5M | -10.51% | ||
| 2022-04-21 | Sale | Chin Mark | 1.75M 6.1916% | $3.05 | $5.32M | -16.98% |
| GordonMD Global Investments LP | 10 percent owner | 15541909 24.5313% | $25.49M | 1 | 0 | |
| PFIZER INC | 10 percent owner | 5952263 9.395% | $9.76M | 1 | 0 | <0.0001% |
| Connealy Pamela Ann | CFO & COO | 1199143 1.8927% | $1.97M | 5 | 0 | +74.64% |
| Cormorant Asset Management, LP | 1118854 1.766% | $1.83M | 1 | 0 | <0.0001% | |
| Wadhane Jitendra | Chief Accounting Officer | 226937 0.3582% | $372,176.68 | 3 | 0 | +107.21% |
| Civik Thomas | director | 15700 0.0248% | $25,748.00 | 1 | 0 | <0.0001% |
| Cline Darren S | director | 10000 0.0158% | $16,400.00 | 1 | 0 | <0.0001% |
| Chin Mark | 0 0% | $0 | 1 | 1 | <0.0001% |
$5,552,811 | 165 | 5.84% | $106.2M | |
$1,701,941 | 56 | 17.58% | $93.09M | |
$66,137,559 | 49 | 6.29% | $89.66M | |
$77,146,704 | 43 | 13.28% | $93.12M | |
$130,095 | 43 | 45.19% | $111.24M |
| Increased Positions | 47 | +59.49% | 9M | +47.7% |
| Decreased Positions | 33 | -41.77% | 6M | -30.52% |
| New Positions | 22 | New | 6M | New |
| Sold Out Positions | 14 | Sold Out | 6M | Sold Out |
| Total Postitions | 93 | +17.72% | 23M | +17.18% |
| Laurion Capital Management Lp | $4,170.00 | 5.85% | 3.63M | 0 | 0% | 2025-09-30 |
| Tang Capital Management Llc | $2,875.00 | 4.03% | 2.5M | 0 | 0% | 2025-09-30 |
| Vanguard Group Inc | $2,489.00 | 3.49% | 2.16M | +14,566 | +0.68% | 2025-09-30 |
| Perceptive Advisors Llc | $1,355.00 | 1.9% | 1.18M | +1M | New | 2025-09-30 |
| Palo Alto Investors Lp | $1,193.00 | 1.67% | 1.04M | 0 | 0% | 2025-09-30 |
| Millennium Management Llc | $938.00 | 1.32% | 815,331 | -3M | -76.97% | 2025-09-30 |
| Stempoint Capital Lp | $793.00 | 1.11% | 689,538 | +689,538 | New | 2025-09-30 |
| Blackrock, Inc. | $786.00 | 1.1% | 683,702 | -243,103 | -26.23% | 2025-09-30 |
| Bank Of America Corp /De/ | $708.00 | 0.99% | 615,922 | +593,853 | +2,690.89% | 2025-09-30 |
| Renaissance Technologies Llc | $663.00 | 0.93% | 576,336 | +158,514 | +37.94% | 2025-09-30 |